WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
฿5.20
0.00%
(0.00) 1D
වප් 15, 16.40.00 ග්‍රිමවේ+7 · THB
search
සියලු සංකේත
| සංකේතය | මිල | වෙනස් කිරීම | % වෙනස |
|---|
insights_autoWUXI06 සඳහා ඉහළම ඇතුළාන්තයන් උත්පාදනය කරමින්...
විවෘත කරන්න
฿5.25
ඉහළ
฿5.35
පහළ
฿5.05
වෙ.පො ප්‍රාග්ධනය
බි200.24
දළ පරිමාව
ද93.60
හඬ පරිමාණය
ද288.50
සති-52 ඉහළ
฿6.25
සති-52 පහළ
฿3.02
ගෙවිය යුතු කොටස්
බි4.12
සේවකයින් ගණන
ද15
විවෘත කරන්න
฿5.25
ඉහළ
฿5.35
පහළ
฿5.05
වෙ.පො ප්‍රාග්ධනය
බි200.24
දළ පරිමාව
ද93.60
හඬ පරිමාණය
ද288.50
සති-52 ඉහළ
฿6.25
සති-52 පහළ
฿3.02
ගෙවිය යුතු කොටස්
බි4.12
සේවකයින් ගණන
ද15
පුවත් සහ කථා
වෙබ් මූලාශ්‍ර සහ ප්‍රවෘත්ති හවුල්කරුවන්ගෙන්
bloomingbit
·
මිනිත්තු 28කට පෙර
Nasdaq-Listed Tron Files $200 Million Stock Offering to Fund TRX Purchases
Hartford Business Journal
·
මිනිත්තු 24කට පෙර
Branford biotech Quantum-Si regains Nasdaq compliance as stock rebounds
ChartMill
·
මිනිත්තු 27කට පෙර
These S&P500 stocks are gapping in today's session
පැතිකඩ
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Wuxi Biologics (Cayman) Inc. KKPS DR ගැන